In brief | Unilever, RB, Venture Life, Futura

In brief | Unilever, RB, Venture Life, Futura
Carl Dempsey has joined the board of Venture Life

5 October 2018 - Deborah Wilkes

News in brief from Unilever, RB, Venture Life and Futura Medical.

Unilever abandons proposal

Unilever has abandoned a proposal to move its headquarters out of the UK and consolidate its corporate structure in the Netherlands. The Anglo-Dutch company said it had not received support from a significant group of shareholders.

RB takes action in Singapore

RB and IPI Singapore have signed a memorandum of understanding with the aim of "finding solutions in a number of future consumer health areas".

Commenting on the initiative, Guy Tweedie, RB's vice president research and development, said: “IPI has a world-leading network of innovators and we are delighted and excited by this partnership potential."

"This region has a great ecosystem in nutrition so our starting point is to work with IPI’s network to translate ground-breaking research in mom and baby nutrition and the impact of the microbiome on their health, into real products for mum and baby in the future," added Tweedie. "This is the beginning of a great partnership which will see us working together with IPI to find health solutions for consumers in a number of areas."

IPI – the Intellectual Property Intermediary – was established under Singapore’s Ministry of Trade and Industry. It focuses on industry needs and translates their innovation objectives into specific technology requirements to enable enterprises to develop new processes, products and services.

Venture Life makes change to board

Venture Life has appointed Carl Dempsey – former worldwide vice president global customer management at Johnson & Johnson – as a non-executive director. Dempsey will replace John Sylvester who has stepped down from the board of the UK-based self-care group.

Futura reports results

Futura Medical reported a loss of GBP1.95 million (USD2.56 million) in the first half of 2018. The UK-based product development company said it had cash resources of GBP6.03 million at 30 June 2018.

Take out an Annual Subscription to the OTCToolbox website, giving you UNLIMITED ACCESS to all of our publications
* Premium News Stories
* OTCToolbox Innovations magazine NEW IDEAS BETTER WAYS
* OTCToolbox Deals Database
* News Extras
* OTC Deal Trends Briefing
* OTC Company Strategies Report
Helping you and your company make well-informed decisions

Click tags below for more information on topics:

Unilever Futura Medical

Back to Industry News

Share this page: